Acabrunat 100mg (Acalabrutinib)

Acabrunat 100mg Capsule is an anticancer medicine containing the active constituent acalabrutinib. It is used to treat mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). MCL, CLL, and SLL are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs and the type of lymphocytes affected.

Before taking this medicine, inform your doctor if you have had recent surgery, bleeding problems, heart rhythm problems, infection, are pregnant, or breastfeeding. Acabrunat 100mg Capsule is not recommended for children and adolescents less than 18 years. Use sun protection as this medicine may put you at the risk of developing skin cancer.

Report to your doctor if you develop a lesion or change in the appearance of an area on the skin. Talk to your doctor about all the medications, including herbal medicines, and supplements, before taking Acabrunat 100mg Capsule. Use effective birth control during the treatment and for at least one week after the last dose. 

Acabrunat 100mg Capsule uses:

The Acabrunat 100mg Capsule indication are

• Chronic lymphocytic leukemia
• Small lymphocytic lymphoma
• Mantle cell lymphoma

How Acabrunat 100 mg Capsule works: 
It blocks the protein BTK (Bruton tyrosine kinase), which helps these cancer cells grow and survive. By blocking this protein, this medication slows the growth and multiplication of cancer cells.
 

Interactions with other drugs:

Inform your physician about any medications you are taking or have taken before the treatment.

More information:

• Keep out of sight and reach of children.
• Store below 30°C.